Axcella's new long COVID medication helps some patients in small trial
Clinical trials of a new drug aimed at tackling symptoms of long COVID, made by Axcella, show that the drug worked in helping some patients overcome their fatigue.
Stay updated with breaking news from Jason Maley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical trials of a new drug aimed at tackling symptoms of long COVID, made by Axcella, show that the drug worked in helping some patients overcome their fatigue.
By Julie Steenhuysen CHICAGO (Reuters) - One of the first trials aimed at tackling long COVID helped some patients recover from lingering physical and...
TodayHeadline Vaccines offer little protection against long Covid, study finds - CNBC –
Inside one COVID-19 long hauler's recovery after a severe case more than two years ago.
Courtesy Heather-Elizabeth Brown(NEW YORK) -- Heather-Elizabeth Brown feels grateful to have survived her bout with severe COVID-19. But more than two years